HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.30 Cr | ₹-14 Cr | ₹15 Cr | ₹3.80 Cr | ₹-24 Cr |
What is the latest Net Cash Inflow / Outflow ratio of HIKAL ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.30 Cr |
| Mar2024 | ₹-14 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹3.80 Cr |
| Mar2021 | ₹-24 Cr |
How is Net Cash Inflow / Outflow of HIKAL Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.30 Cr | Positive | |
| Mar2024 | ₹-14 Cr | Negative | |
| Mar2023 | ₹15 Cr | 301.92 | |
| Mar2022 | ₹3.80 Cr | Positive | |
| Mar2021 | ₹-24 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹3,032.6 Cr | 13% | 40.6% | -29.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 13% |
40.6% |
-29.2% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses